Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

AM580 is a retinoic acid receptor agonist that is selective for RARα (Kd = 8 nM; AC50 = 0.36 nM) compared to RARβ (Kd = 131 nM; AC50 = 24.6 nM) and RARγ (Kd = 450 nM; AC50 = 27.9 nM).1 It demonstrates greater specific binding to RARα compared to retinoic acid (Item No. 11017), which exhibits little selectivity across RARα, β, or γ.1,2,3 AM580 has been used in combination with the GSK3β inhibitor CHIR99021 (Item No. 13122) to efficiently induce differentiation of human induced pluripotent stem cells into immediate mesoderm.4 It can also inhibit the proliferation of various tumor cells, inhibiting survival signaling pathways and inducing apoptosis.5,6
WARNING This product is not for human or veterinary use.
1. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun. 186(2), 977-983 (1992).
2. The role of specific retinoid receptors in sebocyte growth and differentiation in culture. J. Invest. Dermatol. 114(2), 349-353 (2000).
3. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl. Recept. Signal 7, e005 (2009).
4. Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-
5. Mechanism of inhibition of MMTV-
6. Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms. J. Mol. Endocrinol. 46(2), 139-153 (2011).